Flower Mound, TX, United States of America

Jef K De Brabander

This inventor holds 29 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Neurogenic Compounds. Top assignees: The University of Texas System, Ut Southwestern Medical Center. Active years: 2003-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jef K De Brabander. Retrieved from https://idiyas.com/inventor/jef-k-de-brabander

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 

% Patents Active = 41.4

 

 

Average Co-Inventor Count = 3.8

ph-index = 10

Forward Citations = 369(Granted Patents)


Location History:

  • Lewisville, TX (US) (2003 - 2010)
  • Dallas, TX (US) (2007 - 2012)
  • Flower Mound, TX (US) (2013 - 2019)

Company Filing History:


Years Active: 2003-2019

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Anti-Depression Compounds
Pro-Neurogenic Compounds
Cholesterol Biosynthesis
Adenomatous Polyposis Coli
Parkinson's Disease
Traumatic Brain Injury
Post-Traumatic Stress Disorder
Amyotrophic Lateral Sclerosis
Dimeric Small Molecules
Synthetic Salicylihalamides
Apoptosis Potentiators
Methods of Preparation
29 patents (USPTO):Explore Patents

Title: Jef K De Brabander: Innovator in Neurogenesis

Introduction

Jef K De Brabander is an accomplished inventor and researcher based in Flower Mound, TX. With an impressive portfolio of 29 patents, he has made significant contributions to the fields of neurogenesis and neuropharmacology. His innovative research aims to provide therapeutic solutions for various neuropsychiatric and neurodegenerative diseases.

Latest Patents

Among his latest patents, Jef has focused on anti-depression compounds that aim to stimulate neurogenesis and protect neuronal cells from death. These compounds have shown promising in vivo activity, suggesting potential therapeutic benefits for a range of conditions, including schizophrenia, major depression, and Alzheimer's disease. Additionally, his pro-neurogenic compounds further the understanding of stimulating post-natal neurogenesis and offer protective measures against neuron cell death.

Career Highlights

Throughout his career, Jef K De Brabander has worked with esteemed institutions such as the University of Texas System and UT Southwestern Medical Center. His research has not only garnered multiple patents but has also influenced the direction of neuroscience and therapeutic advancements in mental health.

Collaborations

Jef has collaborated with notable peers in his field, including Steven L McKnight and Joseph Ready. These partnerships have enabled the sharing of knowledge and expertise, fostering innovation in neurogenesis research.

Conclusion

Jef K De Brabander’s contributions to the field of neurogenesis exemplify the power of innovation in addressing complex neurological challenges. With his ongoing research and numerous patents, he continues to pave the way for groundbreaking treatments in neuropsychiatric and neurodegenerative disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…